Fortrea Holdings

US · FTRE #2796 by market cap Listed 2023

20.56 -0.22 -1.06%

Live - 5344 symbols - heartbeat 508s ago · 2026-10-08 04:52

Pre-market 20.93 +1.81%

After-hours 20.56 0.00%

Market cap: 1.96B
P/E (TTM): -24.77
P/B: 3.73
EPS: -10.81
Div yield: 0.00%
52W pos: 80%

Reader sentiment Are you bullish or bearish on FTRE?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Accumulating

The number of reporting institutions increased by 3 in the most recent period (2026/Q3).
Total institutional ownership rose 0.1 percentage points.

Institutional ownership

Held by institutions: 106.66% +0.12pp
Institutions: 388 +3
As of: 2026/Q3 vs. prior period

Ownership vs. money flow

Diverging

Institutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund70.96%

Hedge Fund21.21%

Public Company11.47%

Government Pension Fund1.48%

Individual/Insider1.14%

Private Company0.76%

Insurance Company0.59%

Top holders as of 2026-06-30

BlackRock 16.61% · 15.80M sh

The Goldman Sachs Group, Inc. 8.71% · 8.28M sh

Vanguard Capital Management, LLC 5.06% · 4.81M sh

Sessa Capital IM, L.P. 4.83% · 4.59M sh

Vanguard Portfolio Management, LLC 4.01% · 3.82M sh

State Street Global Advisors 3.98% · 3.78M sh

FMR 3.83% · 3.65M sh

Corvex Management LP 3.14% · 2.99M sh

AQR Capital Management 3.02% · 2.87M sh

Geode Capital Management, LLC 2.68% · 2.55M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 23 buys · 24 sells

Name	Role	Stake
Peter Neupert	Independent Director	0.26%
Anshul Thakral	Chief Executive Officer	0.22%
Thomas Pike	Chief Executive Officer	0.17%
Mark Morais	COO & President of Clinical Services	0.09%
Jill McConnell	Chief Financial Officer	0.08%
Erin Russell	Independent Director	0.08%
Edward Pesicka	Independent Director	0.06%
Amrit Ray	Independent Director	0.06%
David Smith	Independent Director	0.04%
A. Sanders	Director	0.04%

Insider transactions most recent Form 4 filings

Date	Name	Role	Type	Shares	Price
2026-09-10	Jill McConnell	Chief Financial Officer	Intent to Sell (Form 144)	-1,032	$17.14
2026-09-09	Jill McConnell	Chief Financial Officer	Intent to Sell (Form 144)	-1,071	$16.53
2026-09-09	Jason Knoblauch	Chief Financial Officer	Other Derivative Acquisition	+144,434	--
2026-09-08	Jill McConnell	Chief Financial Officer	Intent to Sell (Form 144)	-1,051	$16.85
2026-09-08	Mark Morais	COO & President of Clinical Services	Derivative Exercise and Sale	-3,149	$16.85
2026-09-08	Mark Morais	COO & President of Clinical Services	Intent to Sell (Form 144)	-3,149	$16.85
2026-09-08	Carrie Russell	VP of Accounting & Interim Chief Accounting Officer	Derivative Exercise and Sale	-246	$16.85
2026-09-08	Carrie Russell	VP of Accounting & Interim Chief Accounting Officer	Intent to Sell (Form 144)	-246	$16.85
2026-09-07	Mark Morais	COO & President of Clinical Services	Derivative Exercise and Retained	+4,008	--
2026-09-07	Carrie Russell	VP of Accounting & Interim Chief Accounting Officer	Derivative Exercise and Retained	+604	--
2026-08-18	Jill McConnell	Chief Financial Officer	Intent to Sell (Form 144)	-4,892	$18.19
2026-08-18	Mark Morais	COO & President of Clinical Services	Derivative Exercise and Sale	-4,892	$18.19
2026-08-18	Mark Morais	COO & President of Clinical Services	Intent to Sell (Form 144)	-4,892	$18.19
2026-08-17	Mark Morais	COO & President of Clinical Services	Derivative Exercise and Retained	+6,421	--
2026-08-06	Carrie Russell	VP of Accounting & Interim Chief Accounting Officer	Initial Statement of Beneficial	0	--
2026-08-05	Anshul Thakral	Chief Executive Officer	Open Market Disposition	-111,857	$18.06–18.17
2026-08-04	Anshul Thakral	Chief Executive Officer	Derivative Exercise and Sale	-99,869	$19.03–19.28
2026-08-04	Anshul Thakral	Chief Executive Officer	Intent to Sell (Form 144)	-99,869	$19.16
2026-08-03	Anshul Thakral	Chief Executive Officer	Derivative Exercise and Retained	+316,797	--
2026-08-02	David Smith	Independent Director	Other Derivative Acquisition	+15,840	--

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-08 04:52:21 · For reference only, not investment advice and not tailored to your situation.